Fair pricing forum 2021: meeting report
10 November 2021
| Meeting report

Overview
The third biennial Fair Pricing Forum was held online on 13-15 and 20-22 April 2021 to continue the tradition of encouraging dialogue among various stakeholders, with the following objectives:
- To share countries’ experiences, including from the coronavirus disease (COVID-19) pandemic, in ensuring affordability and transparency of prices and costs of health products
- To advance discussion and knowledge on approaches and system factors pertaining to the pricing and R&D of pharmaceutical products for enhancing affordability, transparency, and innovation, and achieving health sustainable development goals
- To increase support for countries to achieve more affordable and fairer access to pharmaceutical products during the COVID-19 pandemic and beyond.
In total, more than 850 people from 125 Member States participated in the Forum and pre-Forum webinar.
WHO Team
Access to Medicines and Health Products (MHP),
Health Product Policy and Standards (HPS),
Medicines Selection, IP and Affordability (MIA)
Number of pages
58
Reference numbers
ISBN: 978-92-4-003858-5